Physician profile
Jesse Moss
NPI 1851399463
$3,782.21
in general payments reported to CMS, 2019-2025
16 companies · $2,274 in 2025
The $2,274 reported for 2025 was more than what 91% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.39 · 2020: $13.98 · 2021: $198 · 2023: $185 · 2024: $1,053 · 2025: $2,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,654 · Travel and Lodging: $604 · Long Term Medical Supply Or Device Loan: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,653.83 |
| Travel and Lodging | $603.87 |
| Long Term Medical Supply Or Device Loan | $254.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,469.92 | 2019-2025 | |
| Inspire Medical Systems, INC. | $765.51 | 2024-2025 | Inspire |
| Stryker Corporation | $453.91 | 2021-2025 | Scopis Ent, Xpress Loprofile |
| Integra Lifesciences Corporation | $273.86 | 2025 | Integra, Cytal, Surgimend |
| Smith+Nephew, INC. | $253.22 | 2024-2025 | Halo, Coblation |
| Glaxosmithkline, LLC. | $159.98 | 2021-2025 | Nucala |
| Abbvie INC. | $145.01 | 2023-2024 | |
| Genzyme Corporation | $51.18 | 2023 | |
| Kerecis Limited | $40.14 | 2019 | |
| Optinose US, INC. | $39.66 | 2020-2025 | |
| Medtronic, INC. | $35.60 | 2024 | Propel |
| Phathom Pharmaceuticals, INC. | $29.48 | 2025 | Voquezna |
| Neurent Medical Limited | $19.17 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Boston Scientific Corporation | $17.25 | 2024 | Watchman Flx |
| Tactile Systems Technology INC | $14.86 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $13.46 | 2023 | Acclarent Aera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.